RxDoctor Payments Data

Evan White, MD

Radiation Oncology · Chula Vista, CANPI 1063701407

Payments from drug & device makers

$769in general payments, 2019–2025

Across 29 payments — averaging $26.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$116
  • AstraZeneca$89
  • KARL Storz Endoscopy-america$59
  • Merck$57
  • Sanofi$48
  • Deciphera Pharmaceuticals Inc.$32
  • plus $369 from 16 others

What the payments were for

  • Food & beverage$769100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$769 in reported general payments places this provider in the 55th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California

Medicare billing

Part B allowed, 2024
$282,446
Medicare patients
73
Services billed
964

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl30$433

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Chula Vista

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →